Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization

▤ Summary

BioTechne and Refeyn introduced a new integrated workflow for characterizing charge and size variants in bispecific antibodies and biosimilars. The solution combines BioTechne’s MauriceFlex icIEF fractionation system with Refeyn’s TwoMP mass photometry platform. The workflow correlates charge heterogeneity with molecular weight and aggregation in about four hours, which helps reduce development risk and manufacturing delays. The companies position the offering as a faster way to evaluate complex biologics with less sample and fewer separate tests.

▦ Linked Companies